Richard Kitsis, MD
News | Cardiovascular Business
Ohio State's Heart and Vascular Center Names 2023 Schottenstein Prize Laureate

December 27, 2023 — The Ohio State University Wexner Medical Center’s Heart and Vascular Center has named Richard Kitsis ...

Home December 27, 2023
Home
For the second time, the EP team at Baptist Health Lexington is pioneering the clinical use of Robotic Magnetic Navigation for the treatment of heart rhythm disorders
News | Robotic Systems
Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease Patients

December 27, 2023 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, and ...

Home December 27, 2023
Home
Partnership will bring Butterfly’s Ultrasound-on-Chip to the robotic intervention market, with revenue anticipated from every unit sold upon commercialization
News | Point-of-Care Ultrasound (POCUS)
Butterfly Network Announces Commercial Agreement with Mendaera for Next-Generation Interventional Robotic System Powered by Butterfly's Ultrasound-on-Chip Technology

December 27, 2023 — Butterfly Network, Inc., a digital health company transforming care through the power of portable ...

Home December 27, 2023
Home
Harlan M. Krumholz, MD, SM, FACC
News | Cardiovascular Business
Harlan M. Krumholz Named Editor-in-Chief of the Journal of the American College of Cardiology

December 26, 2023 — Globally esteemed cardiologist and researcher, Harlan M. Krumholz, MD, SM, FACC, has been named ...

Home December 26, 2023
Home
Results from an ongoing clinical study conducted by Scripps Clinic indicate that MindMics' non-invasive IH technology can detect aortic stenosis by capturing in-ear acoustic vibrations throughout the cardiac cycles
News | Patient Monitors
MindMics Demonstrates Its In-ear Infrasonic Earbud Technology Shows Promise in Detection of Aortic Stenosis and Hearing Heart Murmurs

December 26, 2023 — MindMics, Inc. reported results from a clinical study of revolutionary earbuds that use a new ...

Home December 26, 2023
Home
Company’s proprietary system used to treat initial five patients in first-in-human feasibility study for patients with atrial fibrillation
News | Atrial Fibrillation
Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX Nanosecond Pulsed Field Ablation (nsPFA) Cardiac Catheter

December 26, 2023 — Pulse Biosciences, Inc., a company primarily focused on leveraging its novel and proprietary CellFX ...

Home December 26, 2023
Home
The Diagnostic and Interventional Cardiology (DAIC) team wishes you a very happy holiday season and prosperous New Year!
Feature | Cardiovascular Business
Happy Holidays from the Diagnostic and Interventional Cardiology Team

The Diagnostic and Interventional Cardiology (DAIC) team wishes you a very happy holiday season and prosperous New Year!

Home December 25, 2023
Home
Company appoints Mohammad Shokoohi-Yekta to lead program and industry pioneer Lance Myers as advisor
News | Artificial Intelligence
HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights

December 22, 2023 — HeartBeam, Inc., a medical technology company focused on transforming cardiac care through the power ...

Home December 22, 2023
Home
Study will evaluate investigational Dual Energy Thermocool SmartTouch SF Catheter potential to deliver safe and effective radiofrequency (RF) and pulsed field ablation (PFA)   
News | Atrial Fibrillation
Biosense Webster Begins Enrollment of SmartPulse Study in the U.S. to Evaluate RF and PFA Dual Energy Catheter to Treat Atrial Fibrillation

December 22, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & ...

Home December 22, 2023
Home
TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, announced the successful implantation of its Topaz transfemoral tricuspid heart valve replacement system (“Topaz”) in a patient with a pacemaker at the University Medical Center of Mainz, Germany.
News | Heart Valve Technology
TRiCares Announces Successful Implantation of Minimally Invasive Topaz Tricuspid Heart Valve Replacement System in Patient with a Pacemaker

December 22, 2023 — TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of ...

Home December 22, 2023
Home
Staten Island University Hospital (SIUH), part of Northwell Health, proudly announces its inclusion among the select few hospitals in Northwell Health to achieve the coveted three-star overall quality ratings by the Society of Thoracic Surgeons (STS) for its outstanding cardiothoracic surgery program
News | STS
Staten Island University Hospital's Cardiothoracic Program Achieves Prestigious STS Three-Star Quality Ratings

December 20, 2023 — Staten Island University Hospital (SIUH), part of Northwell Health, proudly announces its inclusion ...

Home December 20, 2023
Home
Experts at the Smidt Heart Institute's new Aortic Surveillance Clinic will monitor patients with aortic aneurysms (illustrated here) or enlarged aortas. Image by Getty.
News | Cardiovascular Surgery
Smidt Heart Institute Opens Aortic Surveillance Clinic

December 20, 2023 — The Smidt Heart Institute at Cedars-Sinai has opened an Aortic Surveillance Clinic for the ...

Home December 20, 2023
Home
Jason McCarthy, Ph.D., associate professor of biomedical research and translational medicine at MMRI
News | Cath Lab
MMRI Publishes Breakthrough Study Detailing a Novel Approach to Minimize Damage After a Heart Attack

December 20, 2023 — Jason R. McCarthy, Ph.D., associate professor of biomedical research and translational medicine and ...

Home December 20, 2023
Home
ECGI vest developed at UCL being worn by a UCL medical student
News | Sudden Cardiac Arrest
Heart Vest Could Help Predict Sudden Cardiac Death Risk

December 19, 2023 — A vest that can map the electrical activity of the heart in fine detail could potentially be used to ...

Home December 19, 2023
Home
BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announced that the first patient was enrolled and treated in its CardiALLO Allogeneic Mesenchymal Cell Therapy Phase I/II trial
News | Cardiovascular Clinical Studies
BioCardia Doses First Patient in CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells for the Treatment of Ischemic Heart Failure of Reduced Ejection Fraction

December 19, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home December 19, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now